Laurus Labs Limited (LAURUSLABS.NS)

Healthcare | Drug Manufacturers Specialty Generic
Income Statement (Quarterly) 2025-06-30 2024-12-31 2024-09-30 2024-06-30
Revenue 15,695,700,000 14,150,500,000 12,237,000,000 11,949,100,000
Cost of Revenue 6,373,500,000 6,101,500,000 5,483,000,000 8,168,900,000
Gross Profit 9,322,200,000 8,049,000,000 6,754,000,000 3,780,200,000
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 2,148,000,000 0 0 2,488,800,000
Operating Expenses 2,148,000,000 6,258,400,000 6,045,800,000 3,128,800,000
Operating Income 7,174,200,000 1,790,600,000 708,200,000 651,400,000
Interest Expense 515,000,000 578,000,000 526,100,000 491,900,000
Income Before Tax 2,248,200,000 1,306,800,000 228,100,000 184,600,000
Income Tax Expense 631,400,000 400,700,000 50,900,000 62,500,000
Net Income 1,630,200,000 923,000,000 198,400,000 125,100,000
Per Share
EPS 3.02 1.71 0.37 0.23
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Revenue 55,539,600,000 50,018,000,000 60,405,500,000 48,885,400,000 47,232,200,000
Cost of Revenue 25,887,100,000 25,397,900,000 27,743,200,000 22,483,200,000 21,973,700,000
Gross Profit 29,652,500,000 24,620,100,000 32,662,300,000 26,402,200,000 25,258,500,000
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 7,368,600,000 2,011,200,000 1,799,600,000 1,637,800,000 1,405,900,000
Operating Expenses 7,921,600,000 21,078,600,000 19,981,200,000 14,675,900,000 11,790,900,000
Operating Income 21,730,900,000 3,948,600,000 12,946,800,000 11,590,500,000 13,467,600,000
Interest Expense 2,126,300,000 1,796,600,000 1,651,700,000 757,600,000 561,200,000
Income Before Tax 4,882,200,000 2,363,600,000 11,089,400,000 10,838,500,000 13,011,100,000
Income Tax Expense 1,298,800,000 681,500,000 3,123,000,000 2,514,200,000 3,172,900,000
Net Income 3,583,200,000 1,605,500,000 7,901,100,000 8,275,200,000 9,835,800,000
Per Share
EPS 6.65 2.98 14.69 15.42 18.36
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Assets
Cash and Cash Equivalents 995,400,000 1,389,400,000 456,700,000 753,500,000
Short Term Investments 443,900,000 24,200,000 191,000,000 5,900,000
Net Receivables 20,409,200,000 16,952,000,000 15,814,100,000 15,072,500,000
Inventory 19,365,400,000 18,454,100,000 16,848,100,000 17,603,000,000
Total Current Assets 43,323,200,000 38,349,700,000 34,616,800,000 33,446,100,000
Property Plant Equipment 43,159,600,000 40,475,300,000 37,001,700,000 32,085,600,000
Goodwill and Intangibles 2,656,200,000 2,653,200,000 2,592,300,000 2,571,300,000
Total Assets 93,355,700,000 83,870,300,000 76,604,000,000 69,680,400,000
Liabilities
Account Payables 9,584,900,000 10,512,400,000 7,106,500,000 8,763,700,000
Short Term Debt 20,559,600,000 17,170,100,000 12,162,300,000 11,406,900,000
Total Current Liabilities 35,397,200,000 31,122,800,000 24,322,600,000 26,810,100,000
Long Term Debt 7,077,700,000 8,603,900,000 7,988,600,000 6,359,700,000
Total Liabilities 47,330,500,000 42,714,600,000 36,117,400,000 36,089,900,000
Shareholders Equity
Retained Earnings 36,264,900,000 33,149,500,000 33,020,100,000 26,249,500,000
Total Shareholders Equity 44,725,600,000 41,109,500,000 40,375,300,000 33,511,900,000
Balance Sheet (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Assets
Cash and Cash Equivalents 995,400,000 1,389,400,000 456,700,000 753,500,000 484,600,000
Short Term Investments 443,900,000 24,200,000 191,000,000 5,900,000 390,700,000
Net Receivables 20,409,200,000 16,952,000,000 15,814,100,000 15,072,500,000 0
Inventory 19,365,400,000 18,454,100,000 16,848,100,000 17,603,000,000 15,754,500,000
Total Current Assets 43,323,200,000 38,349,700,000 34,616,800,000 33,446,100,000 30,748,600,000
Property Plant Equipment 43,159,600,000 40,475,300,000 37,001,700,000 32,085,600,000 22,771,700,000
Goodwill and Intangibles 2,656,200,000 2,653,200,000 2,592,300,000 2,571,300,000 2,556,200,000
Total Assets 93,355,700,000 83,870,300,000 76,604,000,000 69,680,400,000 57,506,900,000
Liabilities
Account Payables 9,584,900,000 10,512,400,000 7,106,500,000 8,763,700,000 11,786,900,000
Short Term Debt 20,559,600,000 17,170,100,000 12,162,300,000 11,406,900,000 10,262,600,000
Total Current Liabilities 35,397,200,000 31,122,800,000 24,322,600,000 26,810,100,000 24,571,500,000
Long Term Debt 7,077,700,000 8,603,900,000 7,988,600,000 6,359,700,000 4,554,300,000
Total Liabilities 47,330,500,000 42,714,600,000 36,117,400,000 36,089,900,000 31,499,900,000
Shareholders Equity
Retained Earnings 36,264,900,000 33,149,500,000 33,020,100,000 26,249,500,000 18,832,900,000
Total Shareholders Equity 44,725,600,000 41,109,500,000 40,375,300,000 33,511,900,000 25,975,500,000
Cash Flow Statement (Quarterly) 2025-03-31 2024-03-31 2023-03-31 2022-03-31
Operating Activities
Net Income 3,583,200,000 1,605,500,000 11,089,400,000 10,838,500,000
Depreciation & Amortization 4,300,900,000 3,845,800,000 3,240,800,000 2,514,900,000
Stock Based Compensation 102,300,000 109,200,000 74,800,000 66,400,000
Change in Working Capital -3,746,000,000 -290,200,000 -3,152,600,000 -3,416,100,000
Operating Cash Flow 6,016,500,000 6,656,900,000 9,939,000,000 9,111,000,000
Investing Activities
Capital Expenditure -6,410,000,000 -6,783,100,000 -9,901,600,000 -8,768,400,000
Investments -6,410,000,000 -6,783,100,000 -9,901,600,000 -8,768,400,000
Investing Cash Flow -6,817,200,000 -8,224,200,000 -9,960,600,000 -9,143,400,000
Financing Activities
Debt Repayment 1,870,700,000 5,410,500,000 -2,468,300,000 -1,677,700,000
Common Stock Issued/Repurchased 101,700,000 25,600,000 2,468,299,999 43,100,000
Dividends Paid -431,300,000 -861,800,000 -1,074,700,000 -858,600,000
Financing Cash Flow 392,800,000 2,498,300,000 -266,400,000 302,600,000
Summary
Free Cash Flow -393,500,000 -126,200,000 37,400,000 342,600,000
Net Change in Cash -394,000,000 932,700,000 -296,800,000 268,900,000
Cash Flow Statement (Annual) 2025-03-31 2024-03-31 2023-03-31 2022-03-31 2021-03-31
Operating Activities
Net Income 3,583,200,000 1,605,500,000 11,089,400,000 10,838,500,000 9,835,800,000
Depreciation & Amortization 4,300,900,000 3,845,800,000 3,240,800,000 2,514,900,000 2,050,700,000
Stock Based Compensation 102,300,000 109,200,000 74,800,000 66,400,000 28,900,000
Change in Working Capital -3,746,000,000 -290,200,000 -3,152,600,000 -3,416,100,000 -5,940,600,000
Operating Cash Flow 6,016,500,000 6,656,900,000 9,939,000,000 9,111,000,000 7,330,000,000
Investing Activities
Capital Expenditure -6,410,000,000 -6,783,100,000 -9,901,600,000 -8,768,400,000 -6,887,700,000
Investments -6,410,000,000 -6,783,100,000 -9,901,600,000 -8,768,400,000 -6,887,700,000
Investing Cash Flow -6,817,200,000 -8,224,200,000 -9,960,600,000 -9,143,400,000 -9,409,900,000
Financing Activities
Debt Repayment 1,870,700,000 5,410,500,000 -2,468,300,000 -1,677,700,000 -957,300,000
Common Stock Issued/Repurchased 101,700,000 25,600,000 2,468,299,999 43,100,000 73,800,000
Dividends Paid -431,300,000 -861,800,000 -1,074,700,000 -858,600,000 -750,400,000
Financing Cash Flow 392,800,000 2,498,300,000 -266,400,000 302,600,000 2,547,000,000
Summary
Free Cash Flow -393,500,000 -126,200,000 37,400,000 342,600,000 442,300,000
Net Change in Cash -394,000,000 932,700,000 -296,800,000 268,900,000 467,700,000